A newly discovered weakness in brain tumor cells could provide a new target for treating glioblastoma, researchers report.
Scientists have long believed that glioblastoma multiforme, the most aggressive type of primary brain tumor, begins in glial cells that make up supportive tissue in the brain or in neural stem cells. Researchers found that the tumors can originate from other types of differentiated cells in the nervous system, including cortical neurons.
According to a new study, neural activity can stimulate the growth of high-grade glioma brain cancers.
Artificial IntelligenceBrain CancerDeep LearningFeaturedGeneticsMachine LearningNeurologyNeuroscienceNeurotechOpen Neuroscience Articles··3 min read
A new convolutional neural network that utilizes MRI brain scans can forecast genetic mutations in glioma brain tumors.
Researchers report they might have discovered why some people are resistant to standard treatments for brain cancer, and it's in their DNA.
A new study reports changes in immune function can occur up to five years before the diagnosis of brain cancer, which typically only produces symptoms three months before it is detected.
Based on a large scale meta analysis, researchers report striking differences between children's high grade gliomas, so much so that they could be split into 10 different subtypes based on different characteristics. The findings have important implications for developing new and individualized treatments.
Researchers find possible markers for brain cancers in the neural crest.
According to researchers, combining tricyclic antidepressants with blood thinners increased tumor autophagy in mouse models of glioblastoma brain cancer.